US20150322472A1 - Reducing Template Independent Primer Extension and Threshold Time for Loop Mediated Isothermal Amplification - Google Patents
Reducing Template Independent Primer Extension and Threshold Time for Loop Mediated Isothermal Amplification Download PDFInfo
- Publication number
- US20150322472A1 US20150322472A1 US14/809,635 US201514809635A US2015322472A1 US 20150322472 A1 US20150322472 A1 US 20150322472A1 US 201514809635 A US201514809635 A US 201514809635A US 2015322472 A1 US2015322472 A1 US 2015322472A1
- Authority
- US
- United States
- Prior art keywords
- seq
- ssb
- amplification
- primers
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000007397 LAMP assay Methods 0.000 title abstract description 34
- 102000014914 Carrier Proteins Human genes 0.000 claims abstract 2
- 108091008324 binding proteins Proteins 0.000 claims abstract 2
- 239000000872 buffer Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 239000003155 DNA primer Substances 0.000 claims description 4
- 150000001768 cations Chemical class 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 230000006641 stabilisation Effects 0.000 claims description 3
- 238000011105 stabilization Methods 0.000 claims description 3
- 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 claims description 2
- 238000006073 displacement reaction Methods 0.000 claims description 2
- 230000003321 amplification Effects 0.000 abstract description 45
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 45
- 238000000034 method Methods 0.000 abstract description 11
- 239000000203 mixture Substances 0.000 abstract description 7
- 239000013615 primer Substances 0.000 description 86
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 description 57
- 235000019527 sweetened beverage Nutrition 0.000 description 56
- 238000006243 chemical reaction Methods 0.000 description 40
- 238000011533 pre-incubation Methods 0.000 description 18
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 15
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 15
- 238000011534 incubation Methods 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 11
- 108020004707 nucleic acids Proteins 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 150000007523 nucleic acids Chemical class 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 7
- 238000005251 capillar electrophoresis Methods 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000009830 intercalation Methods 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 108020001019 DNA Primers Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011901 isothermal amplification Methods 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101710116602 DNA-Binding protein G5P Proteins 0.000 description 1
- 101800001466 Envelope glycoprotein E1 Proteins 0.000 description 1
- 101000907783 Homo sapiens Cystic fibrosis transmembrane conductance regulator Proteins 0.000 description 1
- 101000671649 Homo sapiens Upstream stimulatory factor 2 Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 101710162453 Replication factor A Proteins 0.000 description 1
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 description 1
- 101710176276 SSB protein Proteins 0.000 description 1
- 101100443856 Streptococcus pyogenes serotype M18 (strain MGAS8232) polC gene Proteins 0.000 description 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 101150008507 dnaE gene Proteins 0.000 description 1
- 101150035285 dnaE1 gene Proteins 0.000 description 1
- 101150003155 dnaG gene Proteins 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 102000056427 human CFTR Human genes 0.000 description 1
- 102000057100 human USF2 Human genes 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Definitions
- Amplification of target nucleic acids is a fundamental method in modern molecular biology and diagnostics. Factors that adversely affect the outcome of amplification reactions include: extension of primers due to non-specific template annealing during amplification, resulting in false positives (Schlötterer and Tautz, Nucleic Acids Research, 20 (2):211-215 (1992); Ogata and Miura, Nucleic Acids Research, 26(20):4657-4661 (1998); Brukner, et al. Analytical Biochemistry, 339:345-347 (2005)); reduced amplification reaction efficiency and rate due to primer or template secondary structure; and variability of amplification due to primer dimer formation.
- RT room temperature
- LAMP loop-mediated isothermal amplification
- a preparation in general in one aspect, includes a SSB; a thermostable polymerase; at least four oligonucleotide primers, and a buffer.
- the buffer in the preparation has a pH in the range of pH6-pH9, a monovalent salt having a concentration in the range of 0-500 mM, a divalent metal cation having a concentration of 0.5 mM-10 mM and optionally a stabilization agent selected from the group consisting of BSA, glycerol and detergent.
- the SSB in the preparation is an extreme thermophile single strand binding protein (ET SSB) (New England Biolabs, Ipswich, Mass.).
- E SSB extreme thermophile single strand binding protein
- thermostable polymerase in the preparation has strand displacement activity and is active at temperatures of greater than 50° C.
- the preparation is used in a method for amplifying a nucleic acid, which includes adding to the preparation, dNTPs and template nucleic acid; performing LAMP; and obtaining amplified template DNA.
- a method for inhibiting primer extension of a primer in an amplification reaction includes: combining a SSB with a thermostable polymerase, at least four primers and a template nucleic acid in a reaction buffer at a first temperature; performing a LAMP reaction at a second temperature which is greater than the first temperature; and determining the inhibition with respect to the same mixture without the SSB.
- the method includes obtaining an increased rate of LAMP of the template DNA.
- a method for obtaining an increase in a rate of LAMP includes combining a SSB with a thermostable polymerase, at least four primers and a template nucleic acid in a reaction buffer at a first temperature; and immediately or after a lag time at a temperature above 4° C. but below 70° C., performing a LAMP reaction at a second temperature, wherein the increase is determined with respect to the same mixture without the SSB.
- the increase in the rate of amplification is measured by time taken to reach threshold amplification is more than 25%.
- FIGS. 1A-B show the effect on amplification efficiencies when a LAMP reaction mixture (Notomi, et al. (2000)) was tested either immediately after removal of the sample from incubation on ice (solid line); or after a 2 hour pre-incubation of the sample at 25° C. before moving the sample to the 65° C. reaction temperature (dashed line).
- FIGS. 1A and 1B showed that the reaction time to threshold signal for LAMP increased from 25 minutes for samples subjected to 0 hour pre-incubation at 25° C. to 40 minutes for the samples that had been subjected to a 2 hour pre-incubation at 25° C. for a reaction mixture containing Bst DNA polymerase, large fragment, and primers.
- FIG. 1A shows results for reactions that contained LAMP primers, where the primers were forward internal primer (FIP), backward internal primer (BIP), forward external primer (F3) and backward external primer (B3). Results are shown for samples that contained Bst DNA polymerase, large fragment (Bst) only; Bst polymerase plus all primers; and Bst polymerase plus all primers plus lambda DNA template (temp). The deleterious effect of pre-incubation at 25° C. was observed for reactions that contained Bst polymerase and primers.
- FIP forward internal primer
- F3 forward external primer
- B3 backward external primer
- FIG. 1B shows the result of pre-incubation of Bst polymerase with specified LAMP primers (FIP; BIP; F3; B3; FIP+BIP; F3+B3; no primers or all primers) at 25° C. prior to the amplification reaction at 65° C.
- LAMP primers FIP; BIP; F3; B3; FIP+BIP; F3+B3; no primers or all primers
- FIGS. 2A-B show capillary electrophoresis (CE) analysis of primer extension reactions that occurred at 25° C.
- the estimated number of nucleotides based on retention time in the CE is provided on the x-axis and the peak height in relative fluorescence units is given on the y-axis of each electropherogram.
- Primer extension was measured for individual primers in the presence or absence of an ET SSB.
- the results show that ET SSB is capable of protecting primers from undesirable extension reactions in the presence of a DNA polymerase, PoID, during LAMP reaction setup (2 hours at 25° C.). Template DNA was not included in the reaction.
- the observed protection was not primer specific as demonstrated in FIG. 2A , which utilized the BIP primer from the primer set described above and FIG. 2B which utilized a BIP from a different LAMP primer set.
- the LAMP primers were incubated at 1.6 ⁇ M in reaction buffer as follows, with all reactions performed in 25 ⁇ L volumes:
- FIG. 2A shows data obtained using a 5′-FAM labeled lambda1 BIP primer from LAMP primer set used in FIGS. 1A-B , 3 , and 4 A-B (5′-6FAM-GAGAGAATTTGTACCACCTCCCACCGGGCACATAGCAGTCCTAGGGACAGT, IDT) (SEQ ID NO:1).
- FIG. 2B shows data obtained using a 5′-FAM labeled lambda 2 BIP primer from a different set of LAMP primers (5′-6FAM -3′) CAGGACGCTGTGGCATTGCAGATCATAGGTAAAGCGCCACGC (SEQ ID NO:2).
- FIG. 3 shows the results of an assay for determining optimal amounts of ET SSB (1-3 ⁇ g) in the reaction mixture.
- a single sample was divided into two aliquots. One aliquot was amplified immediately after removal from setup on ice (solid line). The second aliquot was amplified after the sample was pre-incubated at RT (25° C.) for 2 hours (dashed line). An increase in the rate of the amplification reaction as measured by a reduction in threshold time was observed, with the greatest stimulation observed above 1 ⁇ g ET SSB (reactions performed in 25 A volume). The lag time between immediate (solid) and 2 hour incubated (dashed) samples also decreased, with an approximately 100% (20 minutes) delay observed without ET SSB, but no delay observed with 2 ⁇ g ET SSB. This demonstrates that ET SSB added to primers during the pre-incubation at RT enhanced amplification rates.
- FIGS. 4A-B show the beneficial effect of ET SSB on threshold time for amplification and protection of primers from non-template extension.
- FIG. 4A shows percent stimulation in threshold time for LAMP of target DNA when 0-3 ⁇ g ET SSB was added to primers prior to amplification (no incubation time). Concentrations of 1.5-3.0 ⁇ g ET SSB added to 25 ⁇ L reactions resulted in greater than 50% stimulation of amplification as measured by decreasing time to amplification threshold.
- FIG. 4B shows the effect of 0-3 ⁇ g ET SSB on protection of primers from non-template extension due to pre-incubation at RT prior to performing LAMP reactions. 100% protection of the primers was achieved by use of 1-3 ⁇ g ET SSB added to 25 ⁇ L reactions. Protection was measured by difference between threshold times of the sample with no pre-incubation and the sample pre-incubated at RT for 2 hours, with no threshold time delay defined as 100% protection.
- a stimulation of amplification reaction efficiency can decrease time to reach a defined threshold level of amplification, minimizing required reaction and diagnostic times.
- the beneficial effect of SSBs is observed when the time to reach the defined threshold is decreased.
- An increase in the rate of LAMP has been identified when SSBs are added to a buffer in which the reaction is subsequently performed. The increase in rate is measured by the time required to achieve a threshold yield of amplicon.
- the observed increase is at least 50% when SSB is added to a polymerase primer mix at, for example, one to two molar equivalents of the DNA primers or for example 0.5-10 ⁇ g, 1.0-5 ⁇ g or 1.5-3.0 ⁇ g of SSB.
- Threshold times may be based on sufficient amplification to produce a detectable signal, for example, a fluorescent signal with an intercalating dye on a real time fluorimeter in the range of 100-500,000 RFU, preferably at least 1000 RFU.
- turbidity methods can be used where threshold is defined as dT/dt greater than 0.1.
- protection from non-template primer extension is also provided by the SSB. While the protection from non-template primer extension is not primer dependent and is observed for primers regardless of sequence, some variation in the extent of protection may occur. However, in all cases, the benefit is significant.
- the protection can range from 25% to 100% where 100% protection is equivalent to the optimal efficiency of amplification when a sample is removed from a 4° C. environment and immediately amplified without any RT incubation and 0% is the protection against non-template primer extension afforded after a pre-incubation of primers with polymerase for 2 hours at 25° C. in the absence of SSB (see FIGS. 2A-B and 4 A-B).
- Protection can be achieved when an SSB is added to a polymerase primer mix at, for example, one to two molar equivalents of the DNA primers or for example 0.5-10 ⁇ g, 1.0-5 ⁇ g or 1.5-3.0 ⁇ g of SSB in a 25-50 ⁇ l reaction.
- the addition of SSB protects against the negative consequences of RT setup of amplification reactions prior to raising the temperature to initiate amplification as the SSB prevents primer extension to an extent of at least 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%.
- the pre-incubation time although exemplified as 2 hours at RT could be as little as 5 minutes or as much as 24 hours.
- the pre-incubation temperature although exemplified by 25° C. is intended to include any temperature greater than 4° C. and less than 50° C.
- the present methods and compositions can be used for a hot start amplification in which any non-template primer extension is blocked at RT in the presence of SSB prior to raising the temperature to 50° C-70° C. in an isothermal reaction such as LAMP.
- SSBs examples include: bacterial SSBs (e.g. E. coli SSB) and phage SSBs (T4 gp32, T7 gp2.5) (Hamdan and Richardson, Annual Review of Biochemistry, 78:205-243 (2009)).
- SSBs from eukaryotic organisms e.g. RPA
- RPA eukaryotic organisms
- ET SSB is a 16 kDa single-stranded DNA binding protein which is fully active after 60 minutes at 95° C. and can destabilize secondary structure, and improve DNA polymerase activity (Richard, et al. Nucleic Acids Research, 32 (3):1065-1074, (2004)).
- the ET SSB can be used for hot start amplification and for PCR, RT-PCR, HDA, RCA, sequencing, and isothermal amplification reactions.
- Thermostable polymerases for use in LAMP include PoID; Bst DNA polymerase large fragment; or mutants thereof; or WarmStart® Bst 2.0 DNA polymerase (New England Biolabs, Ipswich, Mass.) (Notomi et al. (2000); Tanner, et al., BioTechniques, 53:81-89, (2012)).
- LAMP reactions were performed at 65° C. either immediately or with indicated components incubated for 2 hours at 25° C. Reactions were performed in 25 ⁇ L volumes and consisted of 8U Bst DNA Polymerase (New England Biolabs, Ipswich, Mass.), 5 ng ⁇ DNA (New England Biolabs, Ipswich, MA), and LAMP primers used together or separately as shown in FIG. 1A and 1B .
- the primers (Integrated DNA Technologies, Coralville, Iowa) were added to an amplification buffer (20 mM Tris, 10 mM KCl, 10 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , pH 8.8 25° C.) (New England Biolabs, Ipswich, Mass.) and supplemented with additional 6 mM MgSO 4 , 0.01% Tween-20 and 1.4 mM dNTPs.
- FIGS. 1A-B The results are shown in FIGS. 1A-B .
- a lag time of about 15 minutes to reach threshold levels of amplification was calculated in the sample subjected to 2 hour pre-incubation before LAMP reached the threshold value. This decrease in efficiency occurred only when the reaction was incubated in the presence of primers and DNA polymerase, indicating unwanted activity of DNA polymerase on primers at RT.
- FIGS. 2A-B shows that the unmodified primer (i) becomes extended in length when a polymerase is added over the indicated pre-incubation period (ii). This corresponds to the extension products of the fluorescently-labeled primer due to DNA polymerase activity. These extension peaks became diminished in the presence of the increasing amounts of SSB (iii and iv), indicating inhibition of extension of primer in the absence of template.
- FIG. 2A shows data obtained using a 5′-FAM labeled lambda BIP primer (from primer set 1, see Example 1) and
- FIG. 2B shows data obtained using a 5′-FAM labeled lambda BIP primer (from set 2), demonstrating that non-template primer extension and SSB protection are not limited to a specific primer sequence.
- LAMP reactions were set up using 1.6 ⁇ M FIP and BIP, and 0.2 ⁇ M F3 and B3 plus 5 ng ⁇ DNA in a buffer containing 20 mM Tris, 10 mM KCl, 10 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , pH 8.8 25° C. supplemented with additional 6 mM MgSO 4 , 0.01% Tween-20 and 1.4 mM dNTPs. Reactions were all 25 ⁇ L, contained 10U Polymerase D, and were incubated at 65° C.
- Threshold time was defined by fluorescence measurement in Bio-Rad CFX96TM (Bio-Rad, Hercules, Calif.) due to presence of 2 ⁇ M SYTO-9® intercalating dye (Life Technologies, Grand Island, N.Y.). The resulting amplification threshold times are shown in FIG. 3 . The results are shown in FIGS. 3 and 4 A-B.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Compositions and methods are provided for loop mediated isothermal amplification in which single stranded binding proteins are shown to protect primers from non-specific extension and to stimulate the rate of threshold amplification.
Description
- This application is a divisional of U.S. application Ser. No. 13/671,123 filed Nov. 7, 2012 which claims right of priority to U.S. Provisional Application No. 61/560,518 filed Nov. 16, 2011.
- Amplification of target nucleic acids is a fundamental method in modern molecular biology and diagnostics. Factors that adversely affect the outcome of amplification reactions include: extension of primers due to non-specific template annealing during amplification, resulting in false positives (Schlötterer and Tautz, Nucleic Acids Research, 20 (2):211-215 (1992); Ogata and Miura, Nucleic Acids Research, 26(20):4657-4661 (1998); Brukner, et al. Analytical Biochemistry, 339:345-347 (2005)); reduced amplification reaction efficiency and rate due to primer or template secondary structure; and variability of amplification due to primer dimer formation. The effects of these factors are enhanced by room temperature (RT) incubation of complete reaction mixtures prior to placement at specified reaction temperature. This would occur, for example, when large numbers of samples are prepared at one time necessitating a certain amount of sample incubation at RT. Therefore, high-throughput and diagnostic applications are often negatively impacted by reaction set-up at RT. This is a significant issue for molecular diagnostic applications, which, demands a high level of consistency and accuracy.
- Various amplification methods are currently utilized in molecular diagnostics. A popular isothermal amplification diagnostic method is loop-mediated isothermal amplification (LAMP) (Notomi, et al. Nucleic Acids Research, 28(12):e63 (2000)). Typically, LAMP employs a DNA polymerase and a set of four to six synthetic primers that recognize a total of six distinct sequences on the target DNA. Recognizing six distinct sequences makes LAMP extremely specific for a target sequence. Despite the specificity of LAMP, it is adversely affected by unwanted, non-specific primer extension reactions during reaction set-up at RT.
- In general in one aspect, a preparation includes a SSB; a thermostable polymerase; at least four oligonucleotide primers, and a buffer.
- In another aspect, the buffer in the preparation has a pH in the range of pH6-pH9, a monovalent salt having a concentration in the range of 0-500 mM, a divalent metal cation having a concentration of 0.5 mM-10 mM and optionally a stabilization agent selected from the group consisting of BSA, glycerol and detergent.
- In another aspect, the SSB in the preparation is an extreme thermophile single strand binding protein (ET SSB) (New England Biolabs, Ipswich, Mass.).
- In another aspect, the thermostable polymerase in the preparation has strand displacement activity and is active at temperatures of greater than 50° C.
- In another aspect, the preparation is used in a method for amplifying a nucleic acid, which includes adding to the preparation, dNTPs and template nucleic acid; performing LAMP; and obtaining amplified template DNA.
- In general in one aspect, a method for inhibiting primer extension of a primer in an amplification reaction, includes: combining a SSB with a thermostable polymerase, at least four primers and a template nucleic acid in a reaction buffer at a first temperature; performing a LAMP reaction at a second temperature which is greater than the first temperature; and determining the inhibition with respect to the same mixture without the SSB.
- In another aspect, the method includes obtaining an increased rate of LAMP of the template DNA.
- In general in one aspect, a method for obtaining an increase in a rate of LAMP, includes combining a SSB with a thermostable polymerase, at least four primers and a template nucleic acid in a reaction buffer at a first temperature; and immediately or after a lag time at a temperature above 4° C. but below 70° C., performing a LAMP reaction at a second temperature, wherein the increase is determined with respect to the same mixture without the SSB.
- In another aspect, the increase in the rate of amplification is measured by time taken to reach threshold amplification is more than 25%.
-
FIGS. 1A-B show the effect on amplification efficiencies when a LAMP reaction mixture (Notomi, et al. (2000)) was tested either immediately after removal of the sample from incubation on ice (solid line); or after a 2 hour pre-incubation of the sample at 25° C. before moving the sample to the 65° C. reaction temperature (dashed line). - After the pre-incubation, LAMP amplification was performed and the threshold time required to produce a threshold amount of fluorescent signal from a DNA intercalating dye was determined (see also Examples 1 and 2).
- The results in
FIGS. 1A and 1B showed that the reaction time to threshold signal for LAMP increased from 25 minutes for samples subjected to 0 hour pre-incubation at 25° C. to 40 minutes for the samples that had been subjected to a 2 hour pre-incubation at 25° C. for a reaction mixture containing Bst DNA polymerase, large fragment, and primers. -
FIG. 1A shows results for reactions that contained LAMP primers, where the primers were forward internal primer (FIP), backward internal primer (BIP), forward external primer (F3) and backward external primer (B3). Results are shown for samples that contained Bst DNA polymerase, large fragment (Bst) only; Bst polymerase plus all primers; and Bst polymerase plus all primers plus lambda DNA template (temp). The deleterious effect of pre-incubation at 25° C. was observed for reactions that contained Bst polymerase and primers. -
FIG. 1B shows the result of pre-incubation of Bst polymerase with specified LAMP primers (FIP; BIP; F3; B3; FIP+BIP; F3+B3; no primers or all primers) at 25° C. prior to the amplification reaction at 65° C. The deleterious effect of pre-incubation at 25° C. was observed for reactions that contained Bst polymerase and primers -
FIGS. 2A-B show capillary electrophoresis (CE) analysis of primer extension reactions that occurred at 25° C. The estimated number of nucleotides based on retention time in the CE is provided on the x-axis and the peak height in relative fluorescence units is given on the y-axis of each electropherogram. Primer extension was measured for individual primers in the presence or absence of an ET SSB. The results show that ET SSB is capable of protecting primers from undesirable extension reactions in the presence of a DNA polymerase, PoID, during LAMP reaction setup (2 hours at 25° C.). Template DNA was not included in the reaction. The observed protection was not primer specific as demonstrated inFIG. 2A , which utilized the BIP primer from the primer set described above andFIG. 2B which utilized a BIP from a different LAMP primer set. - The LAMP primers were incubated at 1.6 μM in reaction buffer as follows, with all reactions performed in 25 μL volumes:
-
- (i) BIP primer, buffer, 2 hour incubation at 25° C. no ET SSB.
- (ii) BIP primer, 10U PoID polymerase, buffer, 2 hour incubation at 25° C., no ET SSB.
- (iii) BIP primer, 10U PoID polymerase, buffer, 2 hour incubation at 25° C., 1 μg ET SSB.
- (iv) BIP primer, 10U PoID polymerase, buffer, 2 hour incubation at 25° C., 2 μg ET SSB.
- Subsequent to pre-incubation, the 1.6 μM samples were diluted to 5 nM and analyzed using CE. A CE peak can be seen in (i) indicating the unmodified primer, which in (ii) runs significantly larger, corresponding to the extension products of the fluorescently-labeled primer due to DNA polymerase activity. These extension peaks became diminished in the presence of the increasing amounts of SSB (iii and iv), indicating inhibition of extension of the primers at RT.
-
FIG. 2A shows data obtained using a 5′-FAM labeled lambda1 BIP primer from LAMP primer set used inFIGS. 1A-B , 3, and 4A-B (5′-6FAM-GAGAGAATTTGTACCACCTCCCACCGGGCACATAGCAGTCCTAGGGACAGT, IDT) (SEQ ID NO:1). -
FIG. 2B shows data obtained using a 5′-FAM labeledlambda 2 BIP primer from a different set of LAMP primers (5′-6FAM -3′) CAGGACGCTGTGGCATTGCAGATCATAGGTAAAGCGCCACGC (SEQ ID NO:2). -
FIG. 3 shows the results of an assay for determining optimal amounts of ET SSB (1-3 μg) in the reaction mixture. - A single sample was divided into two aliquots. One aliquot was amplified immediately after removal from setup on ice (solid line). The second aliquot was amplified after the sample was pre-incubated at RT (25° C.) for 2 hours (dashed line). An increase in the rate of the amplification reaction as measured by a reduction in threshold time was observed, with the greatest stimulation observed above 1 μg ET SSB (reactions performed in 25 A volume). The lag time between immediate (solid) and 2 hour incubated (dashed) samples also decreased, with an approximately 100% (20 minutes) delay observed without ET SSB, but no delay observed with 2 μg ET SSB. This demonstrates that ET SSB added to primers during the pre-incubation at RT enhanced amplification rates.
-
FIGS. 4A-B show the beneficial effect of ET SSB on threshold time for amplification and protection of primers from non-template extension. -
FIG. 4A shows percent stimulation in threshold time for LAMP of target DNA when 0-3 μg ET SSB was added to primers prior to amplification (no incubation time). Concentrations of 1.5-3.0 μg ET SSB added to 25 μL reactions resulted in greater than 50% stimulation of amplification as measured by decreasing time to amplification threshold. -
FIG. 4B shows the effect of 0-3 μg ET SSB on protection of primers from non-template extension due to pre-incubation at RT prior to performing LAMP reactions. 100% protection of the primers was achieved by use of 1-3 μg ET SSB added to 25 μL reactions. Protection was measured by difference between threshold times of the sample with no pre-incubation and the sample pre-incubated at RT for 2 hours, with no threshold time delay defined as 100% protection. - The problem of variability that arises from sample handling prior to amplification has been solved by the compositions and methods described herein. Primers combined with SSB that are allowed to stand at RT in the presence of polymerase are protected from undesired DNA polymerase dependent replication or extension in the absence of template DNA otherwise observed at temperatures lower than the amplification reaction temperature. This protection is not primer sequence dependent. The protective effect of SSBs results in one or more of the following benefits: reduced variability in threshold times for amplification, shorter times to reach threshold amplification and reduced lag time before amplification is initiated.
- Generally, a stimulation of amplification reaction efficiency can decrease time to reach a defined threshold level of amplification, minimizing required reaction and diagnostic times. The beneficial effect of SSBs is observed when the time to reach the defined threshold is decreased. An increase in the rate of LAMP has been identified when SSBs are added to a buffer in which the reaction is subsequently performed. The increase in rate is measured by the time required to achieve a threshold yield of amplicon. The observed increase is at least 50% when SSB is added to a polymerase primer mix at, for example, one to two molar equivalents of the DNA primers or for example 0.5-10 μg, 1.0-5 μg or 1.5-3.0 μg of SSB.
- Threshold times may be based on sufficient amplification to produce a detectable signal, for example, a fluorescent signal with an intercalating dye on a real time fluorimeter in the range of 100-500,000 RFU, preferably at least 1000 RFU. Alternatively, turbidity methods can be used where threshold is defined as dT/dt greater than 0.1.
- In addition to stimulation of reaction time efficiency, protection from non-template primer extension is also provided by the SSB. While the protection from non-template primer extension is not primer dependent and is observed for primers regardless of sequence, some variation in the extent of protection may occur. However, in all cases, the benefit is significant. The protection can range from 25% to 100% where 100% protection is equivalent to the optimal efficiency of amplification when a sample is removed from a 4° C. environment and immediately amplified without any RT incubation and 0% is the protection against non-template primer extension afforded after a pre-incubation of primers with polymerase for 2 hours at 25° C. in the absence of SSB (see
FIGS. 2A-B and 4A-B). - Protection can be achieved when an SSB is added to a polymerase primer mix at, for example, one to two molar equivalents of the DNA primers or for example 0.5-10 μg, 1.0-5 μg or 1.5-3.0 μg of SSB in a 25-50 μl reaction.
- The addition of SSB protects against the negative consequences of RT setup of amplification reactions prior to raising the temperature to initiate amplification as the SSB prevents primer extension to an extent of at least 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%. The pre-incubation time although exemplified as 2 hours at RT could be as little as 5 minutes or as much as 24 hours. The pre-incubation temperature although exemplified by 25° C. is intended to include any temperature greater than 4° C. and less than 50° C.
- The present methods and compositions can be used for a hot start amplification in which any non-template primer extension is blocked at RT in the presence of SSB prior to raising the temperature to 50° C-70° C. in an isothermal reaction such as LAMP.
- As described above, the protection of primers from extension by SSB under these conditions gives rise to stimulation of amplification efficiency and reduced variability in amplification reactions and enhances reaction performance.
- Examples of SSBs known in the art that may be used in the present methods include: bacterial SSBs (e.g. E. coli SSB) and phage SSBs (T4 gp32, T7 gp2.5) (Hamdan and Richardson, Annual Review of Biochemistry, 78:205-243 (2009)). SSBs from eukaryotic organisms (e.g. RPA) have similar mechanisms of action and interaction in DNA replication and repair processes (Richard, et al. Critical Reviews in Biochemistry and Molecular Biology, 44 (2-3):98-116, (2009)) and may be used herein. While a thermostable SSB is exemplified here, this is not intended to be limiting.
- ET SSB is a 16 kDa single-stranded DNA binding protein which is fully active after 60 minutes at 95° C. and can destabilize secondary structure, and improve DNA polymerase activity (Richard, et al. Nucleic Acids Research, 32 (3):1065-1074, (2004)). The ET SSB can be used for hot start amplification and for PCR, RT-PCR, HDA, RCA, sequencing, and isothermal amplification reactions.
- Thermostable polymerases for use in LAMP include PoID; Bst DNA polymerase large fragment; or mutants thereof; or WarmStart® Bst 2.0 DNA polymerase (New England Biolabs, Ipswich, Mass.) (Notomi et al. (2000); Tanner, et al., BioTechniques, 53:81-89, (2012)).
-
TABLE 1 Examples of oligonucleotides (LAMP primers) showing similar protection and threshold stimulation to that shown in Figures 3, 4A and 4B for SEQ ID NOs: 1 and 2. Target Primer Sequence lambda 1 FIP CAGCCAGCCGCAGCACGTTCGCTCATAGGAGATATGGTAGAGCCGC (SEQ ID NO: 3) BIP GAGAGAATTTGTACCACCTCCCACCGGGCACATAGCAGTCCTAGGGACAGT (SEQ ID NO: 1) F3 GGCTTGGCTCTGCTAACACGTT (SEQ ID NO: 4) B3 GGACGTTTGTAATGTCCGCTCC (SEQ ID NO: 5) Loop F CTGCATACGACGTGTCT (SEQ ID NO: 6) Loop B ACCATCTATGACTGTACGCC (SEQ ID NO: 7) lambda 2 FIP AGGCCAAGCTGCTTGCGGTAGCCGGACGCTACCAGCTTCT (SEQ ID NO: 8) BIP CAGGACGCTGTGGCATTGCAGATCATAGGTAAAGCGCCACGC (SEQ ID NO: 2) F3 AAAACTCAAATCAACAGGCG (SEQ ID NO: 9) B3 GACGGATATCACCACGATCA (SEQ ID NO: 10) Loop F GCATCCCACCAACGGGAA (SEQ ID NO: 11) Loop B CAGATTAAGGA (SEQ ID NO: 12) lambda C FIP CGAACTGTTTCGGGATTGCATTCTGGAACTCCAACCATCGCA (SEQ ID NO: 13) BIP GGAGCCTGCATAACGGTTTCGTCGACTCAATGCTCTTACCTGT (SEQ ID NO: 14) F3 GTTGGTCACTTCGACGTATCG (SEQ ID NO: 15) B3 GCTCGCCGACTCTTCACGAT (SEQ ID NO: 16) Loop F TTTGCAGACCTCTCTGCC (SEQ ID NO: 17) Loop B GGATTTTTTATATCTGCACA (SEQ ID NO: 18) E. coli dnaE FIP CTGCCCCGACGATAGGCTTAATCGTGGTCTGGTGAAGTTCTACGG (SEQ ID NO: 19) BIP TCCAGTGCGACCTGCTGGGTGGGTATTGTTCGCCGCCAGTAC (SEQ ID NO: 20) F3 GATCACCGATTTCACCAACC (SEQ ID NO: 21) B3 CTTTTGAGATCAGCAACGTCAG (SEQ ID NO: 22) Loop F TGCGCCATGTCCCGCT (SEQ ID NO: 23) Loop B TGAGTTAACCCACCTGACG (SEQ ID NO: 24) C. elegans FIP TGTTAAGGCGGACTGTGTTCGTCAAACCGCAACGAGACAGTCT lec-6 (SEQ ID NO: 25) BIP CCGAGATAATTCCACCGTTGGATCCATTCCAGCAGAACAAGAT (SEQ ID NO: 26) F3 GATGTCACGAAAAATTCCCTC (SEQ ID NO: 27) B3 GCAATCCGAGGATCGTCAC (SEQ ID NO: 28) Loop F TGCAAAGCACGTGGTGCC (SEQ ID NO: 29) Loop B ACACAAACTCCAGAGTGTAG (SEQ ID NO: 30) C. elegans FIP CTCTGTGAACGGTCATCACCTCGATGGCTTGAACCGATTGGTATGG lec-10a (SEQ ID NO: 31) BIP CTTACATGGTAATATCCAGCGTGCCACTTCACCACTCGGAGCAC (SEQ ID NO: 32) F3 GAACGTCTCCCTTCAATCC (SEQ ID NO: 33) B3 GGACCAGAAATCCGTCACA (SEQ ID NO: 34) Loop F CCGACTACCCACATCGTTAC (SEQ ID NO: 35) Loop B ACCTTGATGCTAAGGTGGAA (SEQ ID NO: 36) C. elegans FIP GATTCCACTTCCAACGTCGTTG-CATAGGCATTGTATCCAGAGTG lec-10b (SEQ ID NO: 37) BIP CGAAGTGAACCTTGTCAACATGAGACTACCCACATCGTTACC (SEQ ID NO: 38) F3 AGCAACATAGGTTTCAGTTC (SEQ ID NO: 39) B3 CTGTGAACGGTCATCACC (SEQ ID NO: 40) Loop F ACGGACATGTCGATCATGGA (SEQ ID NO: 41) Loop B CGTCTCCCTTCAATCCGATGGC (SEQ ID NO: 42) pUC19 AmpR FIP ATGGGGGATCATGTAACTCGCCTCGTCGTTTGGTATGGCTTC (SEQ ID NO: 43) BIP AAGCGGTTAGCTCCTTCGGTCTGCTGCCATAACCATGAGTG (SEQ ID NO: 44) F3 CTACAGGCATCGTGGTGTC (SEQ ID NO: 45) B3 CTTACGGATGGCATGACAGT (SEQ ID NO: 46) Loop F TGGGAACCGGAGCTGAAT (SEQ ID NO: 47) Loop B TCCGATCGTTGTCAGAAGTAAGTTG (SEQ ID NO: 48) Human CFTR FIP CCAAAGAGTAAAGTCCTTCTCTCTCGAGAGACTGTTGGCCCTTGAAGG (SEQ ID NO: 49) BIP GTGTTGATGTTATCCACCTTTTGTGGACTAGGAAAACAGATCAATAG (SEQ ID NO: 50) F3 TAATCCTGGAACTCCGGTGC (SEQ ID NO: 51) B3 TTTATGCCAATTAACATTTTGAC (SEQ ID NO: 52) Loop F ATCCACAGGGAGGAGCTCT (SEQ ID NO: 53) Loop B CTCCACCTATAAAATCGGC (SEQ ID NO: 54) Human FIP GGGCGTGGTAGCGCAGACCAGTCAAGTGATCCTCCTGCCTCAG BRCA-1 (SEQ ID NO: 55) BIP GAGGTTTCCCTATGTTGCCCAGGCCCAAAGTTCAAGGATCACTTGG (SEQ ID NO: 56) F3 CAGCCTCAACCTCCTGGGC (SEQ ID NO: 57) B3 TAATCCCAGCATTTTGGGAG (SEQ ID NO: 58) Loop F GGTCCCAGCTATTTGGAAGG (SEQ ID NO: 59) Loop B TGGTCTTGAACTTCTGGGC (SEQ ID NO: 60) - All references cited herein, as well as U.S. application Ser. No. 13/671,123 filed Nov. 7, 2012 and U.S. Provisional Application Ser. No. 61/560,518 filed Nov. 16, 2011, are hereby incorporated by reference.
- LAMP reactions were performed at 65° C. either immediately or with indicated components incubated for 2 hours at 25° C. Reactions were performed in 25 μL volumes and consisted of 8U Bst DNA Polymerase (New England Biolabs, Ipswich, Mass.), 5 ng λ DNA (New England Biolabs, Ipswich, MA), and LAMP primers used together or separately as shown in
FIG. 1A and 1B . -
Primers: (1.6 μM FIP 5'-CAGCCAGCCGCAGCACGTTCGCTCATAGGAGATATGGTAGAGCCGC (SEQ ID NO: 3); 1.6 μM BIP 5'GAGAGAATTTGTACCACCTCCCACCGGGCACATAGCAGTCCTAGGGA CAGT (SEQ ID NO: 1); 0.2 μM F3 5'-GGCTTGGCTCTGCTAACACGTT (SEQ ID NO: 4); and 0.2 μM B3 5'-GGACGTTTGTAATGTCCGCTCC. (SEQ ID NO: 5)) - The primers (Integrated DNA Technologies, Coralville, Iowa) were added to an amplification buffer (20 mM Tris, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, pH 8.8 25° C.) (New England Biolabs, Ipswich, Mass.) and supplemented with additional 6 mM MgSO4, 0.01% Tween-20 and 1.4 mM dNTPs.
- The results are shown in
FIGS. 1A-B . - A lag time of about 15 minutes to reach threshold levels of amplification was calculated in the sample subjected to 2 hour pre-incubation before LAMP reached the threshold value. This decrease in efficiency occurred only when the reaction was incubated in the presence of primers and DNA polymerase, indicating unwanted activity of DNA polymerase on primers at RT.
- Single LAMP primers with 5′-conjugated fluorophores were incubated at RT for 2 hours under various conditions to demonstrate non-template addition by DNA polymerase and inhibition of this extension by SSB. The primers were incubated at 1.6 μM in amplification buffer as follows, with all reactions performed in 25 μL volumes:
-
- (i) BIP primer (from
set 1 or 2), amplification buffer, 2 hour incubation at 25° C. no ET SSB. - (ii) BIP primer, 10U PoID polymerase, amplification buffer, 2 hour incubation at 25° C., no ET SSB.
- (iii) BIP primer, 10U PoID polymerase, amplification buffer, 2 hour incubation at 25° C., 1 μg ET SSB.
- (iv) BIP primer, 10U PoID polymerase, amplification buffer, 2 hour incubation at 25° C., 2 μg ET SSB.
- (i) BIP primer (from
- Subsequent to pre-incubation, the primers were diluted to 5nM and analyzed using CE (
FIGS. 2A-B ).FIGS. 2A-B shows that the unmodified primer (i) becomes extended in length when a polymerase is added over the indicated pre-incubation period (ii). This corresponds to the extension products of the fluorescently-labeled primer due to DNA polymerase activity. These extension peaks became diminished in the presence of the increasing amounts of SSB (iii and iv), indicating inhibition of extension of primer in the absence of template.FIG. 2A shows data obtained using a 5′-FAM labeled lambda BIP primer (from primer set 1, see Example 1) andFIG. 2B shows data obtained using a 5′-FAM labeled lambda BIP primer (from set 2), demonstrating that non-template primer extension and SSB protection are not limited to a specific primer sequence. - LAMP reactions were set up using 1.6 μM FIP and BIP, and 0.2 μM F3 and B3 plus 5 ng λ DNA in a buffer containing 20 mM Tris, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, pH 8.8 25° C. supplemented with additional 6 mM MgSO4, 0.01% Tween-20 and 1.4 mM dNTPs. Reactions were all 25 μL, contained 10U Polymerase D, and were incubated at 65° C. Threshold time was defined by fluorescence measurement in Bio-Rad CFX96™ (Bio-Rad, Hercules, Calif.) due to presence of 2 μM SYTO-9® intercalating dye (Life Technologies, Grand Island, N.Y.). The resulting amplification threshold times are shown in
FIG. 3 . The results are shown in FIGS. 3 and 4A-B.
Claims (7)
1. A preparation, comprising: a single stranded binding protein (SSB); a thermostable polymerase; at least four oligonucleotide primers, and a buffer.
2. A preparation according to claim 1 , wherein the buffer has a pH in the range of pH6-pH9, and optionally a stabilization agent selected from the group consisting of BSA, glycerol and detergent.
3. A preparation according to claim 1 wherein the buffer comprises a monovalent salt having a concentration in the range of 0-500 mM.
4. A preparation according to claim 1 wherein the buffer comprises a divalent metal cation having a concentration of 0.5 mM-10 mM.
5. A preparation according to claim 1 , wherein the buffer has a pH in the range of pH6-pH9, a monovalent salt having a concentration in the range of 0-500 mM, a divalent metal cation having a concentration of 0.5 mM-10 mM and optionally a stabilization agent selected from the group consisting of BSA, glycerol and detergent.
6. A preparation according to claim 1 , wherein the SSB is an extreme thermophile single strand binding protein (ET SSB).
7. A preparation according to claim 1 , wherein the thermostable polymerase has strand displacement activity and is active at temperatures of greater than 50° C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/809,635 US20150322472A1 (en) | 2011-11-16 | 2015-07-27 | Reducing Template Independent Primer Extension and Threshold Time for Loop Mediated Isothermal Amplification |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161560518P | 2011-11-16 | 2011-11-16 | |
US13/671,123 US9121046B2 (en) | 2011-11-16 | 2012-11-07 | Reducing template independent primer extension and threshold time for loop mediated isothermal amplification |
US14/809,635 US20150322472A1 (en) | 2011-11-16 | 2015-07-27 | Reducing Template Independent Primer Extension and Threshold Time for Loop Mediated Isothermal Amplification |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/671,123 Division US9121046B2 (en) | 2011-11-16 | 2012-11-07 | Reducing template independent primer extension and threshold time for loop mediated isothermal amplification |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150322472A1 true US20150322472A1 (en) | 2015-11-12 |
Family
ID=48281014
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/671,123 Active 2033-07-13 US9121046B2 (en) | 2011-11-16 | 2012-11-07 | Reducing template independent primer extension and threshold time for loop mediated isothermal amplification |
US14/809,635 Abandoned US20150322472A1 (en) | 2011-11-16 | 2015-07-27 | Reducing Template Independent Primer Extension and Threshold Time for Loop Mediated Isothermal Amplification |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/671,123 Active 2033-07-13 US9121046B2 (en) | 2011-11-16 | 2012-11-07 | Reducing template independent primer extension and threshold time for loop mediated isothermal amplification |
Country Status (1)
Country | Link |
---|---|
US (2) | US9121046B2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017136387A1 (en) | 2016-02-01 | 2017-08-10 | Integrated Dna Technologies, Inc. | Cleavable primers for isothermal amplification |
WO2017141067A1 (en) | 2016-02-16 | 2017-08-24 | The University Of Tokyo | Method of eliminating background amplification of nucleic acid targets |
US11732315B2 (en) | 2020-03-12 | 2023-08-22 | New England Biolabs, Inc. | Rapid diagnostic test for lamp |
US10968493B1 (en) | 2020-03-12 | 2021-04-06 | New England Biolabs, Inc. | Rapid diagnostic test using colorimetric LAMP |
US11345970B2 (en) | 2020-03-12 | 2022-05-31 | New England Biolabs, Inc. | Rapid diagnostic test for LAMP |
EP4118233A1 (en) | 2020-03-12 | 2023-01-18 | New England Biolabs, Inc. | A rapid diagnostic test for lamp |
CN111766387B (en) * | 2020-07-10 | 2022-02-01 | 北京华益精点生物技术有限公司 | Preparation method of quality control card and quality control card |
EP4110945A2 (en) | 2020-08-21 | 2023-01-04 | New England Biolabs, Inc. | A rapid diagnostic test for lamp |
WO2025129195A1 (en) | 2023-12-15 | 2025-06-19 | New England Biolabs, Inc. | Dna polymerases and related methods |
CN117925874B (en) * | 2024-03-21 | 2024-06-18 | 北京起源聚禾生物科技有限公司 | Primer probe combination and kit for detecting pathogenic microorganisms and drug resistance genes of urinary tract infection |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010083561A1 (en) * | 2009-01-21 | 2010-07-29 | Human Genetic Signatures Pty Ltd | Improved isothermal strand displacement amplification |
US20120122161A1 (en) * | 2009-05-22 | 2012-05-17 | Esther Musgrave-Brown | Sorting Asymmetrically Tagged Nucleic Acids by Selective Primer Extension |
US20140045221A1 (en) * | 2011-04-20 | 2014-02-13 | Mesa Tech International, Inc. | Oscillating Amplification Reaction for Nucleic Acids |
-
2012
- 2012-11-07 US US13/671,123 patent/US9121046B2/en active Active
-
2015
- 2015-07-27 US US14/809,635 patent/US20150322472A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010083561A1 (en) * | 2009-01-21 | 2010-07-29 | Human Genetic Signatures Pty Ltd | Improved isothermal strand displacement amplification |
US20120122161A1 (en) * | 2009-05-22 | 2012-05-17 | Esther Musgrave-Brown | Sorting Asymmetrically Tagged Nucleic Acids by Selective Primer Extension |
US20140045221A1 (en) * | 2011-04-20 | 2014-02-13 | Mesa Tech International, Inc. | Oscillating Amplification Reaction for Nucleic Acids |
Also Published As
Publication number | Publication date |
---|---|
US9121046B2 (en) | 2015-09-01 |
US20130122551A1 (en) | 2013-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9121046B2 (en) | Reducing template independent primer extension and threshold time for loop mediated isothermal amplification | |
JP6574178B2 (en) | Ligase-assisted nucleic acid circularization and amplification | |
CN104685066B (en) | Compositions and methods for quantifying nucleic acid sequences in a sample | |
EP2582850B1 (en) | Compositions, kits, and methods for synthesis and/or detection of nucleic acids | |
EP1446508B1 (en) | A method of reducing non-specific amplification in pcr | |
JP2009284896A (en) | Nucleic acid amplification method | |
US20180171399A1 (en) | Helicase Suppression of Non-Template Amplification | |
EP2103693A1 (en) | Nucleic acid amplification in the presence of modified randomers | |
WO2016135300A1 (en) | Efficiency improving methods for gene library generation | |
RU2018144299A (en) | RING DNA AMPLIFICATION METHOD | |
US9212378B2 (en) | Method of amplifying DNA from RNA in a sample | |
US20020172972A1 (en) | Use of a selectively inactivatable enzyme to digest contaminating nucleic acid | |
US20090286251A1 (en) | Enzyme Reagents for Amplification of Polynucleotides in the Presence of Inhibitors | |
US8685648B2 (en) | Endonuclease-enhanced helicase-dependent amplification | |
EP3464596B1 (en) | Thermostable polymerase inhibitor compositions and methods | |
KR20140123858A (en) | Polynucleotide and use thereof | |
EP3250715A1 (en) | Substrate molecule | |
US20240218438A1 (en) | Improvements in or relating to digestion of reaction products | |
CN104093835A (en) | Method for improving nucleic acid synthesis reaction | |
JP2008178338A (en) | Nucleic acid amplification method for amplifying target nucleic acid in nucleic acid sample contaminated with fragmented nucleic acid, and kit thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NEW ENGLAND BIOLABS, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TANNER, NATHAN;EVANS, THOMAS C., JR.;REEL/FRAME:036189/0842 Effective date: 20121107 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |